Please Wait
Applying Filters...
menu
    • menu
    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-23

    Virtual Booth

    An Enquiry

    Menu

    Lactose Monohydrate

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3BUDESONIDE

    02 1DELZICOL

    03 2FENOFIBRIC ACID

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    ABBVIE
    U.S.A
    arrow
    ACS GCI
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MESALAMINE

    Drug : DELZICOL

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 204412

    Country : US

    Patented : No

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    AUROBINDO PHARMA USA

    BUDESONIDE

    arrow
    ACS GCI
    Not Confirmed
    AUROBINDO PHARMA USA
    India
    arrow
    ACS GCI
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BUDESONIDE

    Drug : BUDESONIDE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 90410

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    BARR LABS DIV TEVA

    BUDESONIDE

    arrow
    ACS GCI
    Not Confirmed
    BARR LABS DIV TEVA
    U.S.A
    arrow
    ACS GCI
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BUDESONIDE

    Drug : BUDESONIDE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 90379

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    CHARTWELL RX

    CHOLINE FENOFIBRATE

    arrow
    ACS GCI
    Not Confirmed
    CHARTWELL RX
    U.S.A
    arrow
    ACS GCI
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CHOLINE FENOFIBRATE

    Drug : FENOFIBRIC ACID

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 200750

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    ENDO OPERATIONS

    CHOLINE FENOFIBRATE

    arrow
    ACS GCI
    Not Confirmed
    ENDO OPERATIONS
    Ireland
    arrow
    ACS GCI
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CHOLINE FENOFIBRATE

    Drug : FENOFIBRIC ACID

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 201573

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    RISING

    BUDESONIDE

    arrow
    ACS GCI
    Not Confirmed
    RISING
    U.S.A
    arrow
    ACS GCI
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BUDESONIDE

    Drug : BUDESONIDE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 207367

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF